Shuttle Pharmaceuticals Stock (NASDAQ: SHPH)

Shuttle Pharmaceuticals Stock (NASDAQ:SHPH), Trade Ideas

Shuttle Pharmaceuticals

Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADXN

CLDI

DFLI

DYNT

ENSV

ERIC

GRPN

KXIN

MCBC

RVYL

SHPH

SPCB

SPRC

TAOP

USEG

WISA

WFTC

Shares of  Macatawa Bank Corporation (NASDAQ: MCBC) rose sharply in today’s pre-market trading after Wintrust Financial Corporation (NASDAQ: WFTC) and Macatawa Bank announced that they have entered into a definiti

Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket

Intraday Update

ABSI

ADAG

AGAE

AGFY

ALLY

ASTS

AXDX

AZTR

BCDA

BFRG

CELH

CHGG

CISS

CRGE

DTSS

ESPR

EWTX

GOOG

GOOGL

IRBT

KAMN

MESA

MESO

Morgan Stanley Capital Protected Notes for S&P 500 Index

NAMS

NKTX

ORGS

PCSA

PRTG

RNAZ

SAVE

SILK

SMCI

SOAR

VMAR

WRLD

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session.

TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share.

TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.

Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

AMAM

AMPE

ARBK

ARDX

AREN

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

AXNX

BCRX

BFLY

BNZI

BSGM

CROX

CYCC

DADA

DVAX

ELEV

FSLY

HARP

LMDX

NEXI

PACB

PRAX

PRTA

RGNX

RVNC

RXST

SNMP

SPEC

STSS

STTK

TCJH

TREE

UPWK

VERO

VINC

ZJYL

Shares of  RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates.

Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Shuttle Pharmaceuticals Holdings, Inc. - common stock

Shuttle Pharmaceuticals Holdings Inc

SIHUAN PHARM HOLDINGS GP by Sihuan Pharmaceutical Holdings Group Ltd.

Sihuan Pharmaceutical Holdings Group Ltd

SIHUAN PHARM HLDGS ADR by Sihuan Pharmaceutical Holdings Group Ltd.

Meta Platforms&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) CEO&nbsp;Mark Zuckerberg&nbsp;has acknowledged pop star&nbsp;Taylor Swift&#8217;s debut on his social media platform Threads during the company&#8217;s <a href="https://www.benzinga.com/news/earnings/24/04/38416273/meta-platforms-q1-earnings-highlights-facebook-owner-beats-estimates-but-guidance-higher-costs-ding">first-quarter financial results</a> announcement.
What Happened: On Wednesday, in his opening statement, Zuckerberg, mentioned <a href="https://www.benzinga.com/news/23/10/35431135/are-reports-of-metas-threads-death-greatly-exaggerated-mark-zuckerberg-says-the-twitter-killer-has-a">the growth of Threads</a>, with over 150 million monthly active users. 
He then went on to specifically highlight Swift&#8217;s entry on the platform saying, &#8220;And of course my daughters&nbsp;would want me to mention&nbsp;that Taylor Swift is now&nbsp;on Threads — that one&nbsp;was a big deal in&nbsp;my house.&#8221; 
See Also:&nbsp;<a href="https://www.benzinga.com/markets/equities/24/04/38348747/not-something-steve-jobs-would-probably-do-gurman-says-apple-should-go-against-the-grain-and-low?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Mark Zuckerberg Sports A Beard In A New Instagram Video…Is That For Real?</a>
Swift joined Threads on the&nbsp;same day (April 19) her new album,&nbsp;The Tortured Poets Department (TTPD), was released. Zuckerberg welcomed her to the platform with a reference to her song &#8220;Blank Space,&#8221;&nbsp;saying, &#8220;Nice to meet you,&nbsp;where you been?&#8221; At the&nbsp;time of writing, Swift had&nbsp;over 9.3 million followers on&nbsp;Threads.
<figure class="wp-block-image size-large"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/24211150/Screenshot-2024-04-25-at-6.41.43%E2%80%AFAM-720x1024.png" alt="" class="wp-image-307578" /></figure>
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: This isn&#8217;t the first time Zuckerberg has shown his admiration for Swift. In 2023, he <a href="https://www.benzinga.com/general/entertainment/23/07/33477808/zuckerberg-has-bad-blood-with-musk-but-love-story-with-taylor-swift-attends-concert-with-be">attended one of her concerts</a> with his family,&nbsp;posting about it on Instagram&nbsp;with the caption &#8220;Life of a girl dad.&#8221; 
At the time, the Meta CEO was not only there to accompany his family but sported a flurry of friendship bracelets on his wrist, which has become trademark accessories&nbsp;of any true &#8220;Swiftie.&#8221; On top of that, his face was adorned with what seemed to be small sequins or rhinestones arranged in a circle.
<figure class="wp-block-image size-large"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/24211656/Screenshot-2024-04-25-at-6.46.27%E2%80%AFAM-1024x1022.png" alt="" class="wp-image-307581" /></figure>
Meta reported its first-quarter financial results, which showed a 27% year-over-year increase in revenue, reaching $36.45 billion. In the first quarter, the company announced earnings per share of $4.71, surpassing the Street&#8217;s estimate of $4.33.
Image Credits &#8211; Shutterstock
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:&nbsp;<a href="https://www.benzinga.com/general/entertainment/24/04/38345794/mark-zuckerberg-spills-the-beans-on-his-bromance-with-nvidias-jensen-huang-hell-yeah-lets-m" target="_blank" rel="noreferrer noopener">Mark Zuckerberg Spills The Beans On His Bromance With Nvidia's Jensen Huang: ‘Hell Yeah, Let's Make Cheesesteaks</a>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Entertainment

Social Media

Tech

Mark Zuckerberg Gives Shoutout To Taylor Swift's Debut On Threads, Says 'That One Was A Big Deal In My House'

Edward Snowden has slammed the U.S. Department of Justice&#8217;s recent actions against app developers, advocating for financial privacy in a recent social media post.
What Happened: On Tuesday, Snowden took to X, formerly Twitter, to express his disapproval of the Department of Justice&#8217;s recent actions. He tweeted, &#8220;The Department of &#8216;Justice&#8217; has once again criminalized the developers of an app that restores financial privacy. The way to fix this it to make money private by default. Privacy must never be &#8216;exceptional,&#8217; or they will make it criminal.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The Department of &quot;Justice&quot; has once again criminalized the developers of an app that restores financial privacy. The way to fix this it to make money private by default. Privacy must never be &quot;exceptional,&quot; or they will make it criminal.
&mdash; Edward Snowden (@Snowden) <a href="https://twitter.com/Snowden/status/1783222542464884911?ref_src=twsrc%5Etfw">April 24, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
This post came in response to the recent arrest and charges against the founders and CEO of a cryptocurrency mixing service. 
The founders and CEO of cryptocurrency mixing service, Samourai Wallet, have been arrested and charged with money laundering and unlicensed money transmitting offenses. The charges stem from the company&#8217;s alleged involvement in over $2 billion in unlawful transactions and more than $100 million in money laundering transactions.
According to the United States Department of Justice, Keonne Rodriguez, CEO and co-founder of Samourai Wallet, and William Lonergan Hill, CTO and co-founder, were arrested on Wednesday. The charges arise from the defendants&#8217; development, marketing, and operation of a cryptocurrency mixer that facilitated illegal transactions from dark web markets, such as Silk Road and Hydra Market.
U.S. Attorney Damian Williams stated that Rodriguez and Hill knowingly facilitated the laundering of over $100 million of criminal proceeds from various illegal activities. The U.S. will seek Hill&#8217;s extradition from Portugal to stand trial in the United States, he was arrested in the European Union country on Wednesday morning.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38349807/bitcoin-signals-potential-67-gain-as-this-key-metric-dips-below-90-day-average-analyst-say?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bitcoin Signals Potential 67% Gain As This Key Metric Dips Below 90-Day Average: Analyst Says &#8216;Perfect Ti</a>
Why It Matters: Snowden&#8217;s tweet reflects his ongoing support for financial privacy, particularly in the context of cryptocurrency. He has previously <a href="https://www.benzinga.com/markets/cryptocurrency/24/01/36751582/edward-snowden-supports-legal-fund-for-tornado-cash-co-founder-roman-storm-privacy-is-not-">endorsed a legal defense fund</a> for Roman Storm, co-founder of Tornado Cash, a cryptocurrency mixing service embroiled in legal issues. Snowden has been vocal in his belief that &#8220;Privacy is not a crime.&#8221;
This recent post from Snowden also aligns with the views of former U.S. Presidential candidate Vivek Ramaswamy, who has argued that <a href="https://www.benzinga.com/markets/cryptocurrency/23/12/36190138/vivek-ramaswamy-thinks-penalizing-tornado-cash-mixer-was-illegal-and-unconstitutional">penalizing an entire protocol</a> or way of doing business is illegal and unconstitutional. Ramaswamy has specifically criticized the Treasury Department&#8217;s decision to sanction Tornado Cash.
These events highlight the ongoing debate around financial privacy, particularly in the realm of cryptocurrencies like Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), and the legal challenges faced by companies operating in this space.
Photo Courtesy: Wikimedia Commons
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38395178/dogecoin-could-outperform-bitcoin-thanks-to-consolidation-in-the-golden-pocket-says-trader?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Dogecoin Could Outperform Bitcoin Thanks To Consolidation In The Golden Pocket, Says Trader: &#8216;This Is A Very Good Sign&#8217;</a>
<div style="font-family: 'Lato', sans-serif">
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by 
 Benzinga Neuro, Edited by 
 
 <a href="None" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none"> 
 Shivdeep Dhaliwal</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the 
 extensive Benzinga Ecosystem, including native data, APIs, and more to 
 create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Politics

$BTC

$ETH

Edward Snowden Slams Justice Department For Action Against Samourai Wallet Co-Founders: 'The Way To Fix This Is To Make Money Private By Default'

In a recent development, Senate Minority Leader Mitch McConnell (R-Ky.) has lambasted President Joe Biden for the U.S. withdrawal from Afghanistan, suggesting it served as a &#8220;green light&#8221; for Russian President Vladimir Putin.
What Happened: McConnell expressed his disapproval on Fox News&#8217;s &#8220;America&#8217;s Newsroom&#8221; following the Senate&#8217;s approval of an aid package for Ukraine after a long delay, <a href="https://thehill.com/policy/international/4619508-mcconnell-hits-biden-for-sending-a-green-light-to-putin-with-afghanistan-withdrawal/">reported</a> The Hill.
McConnell asserted that the Afghanistan exit was a major misstep by Biden, indicating weakness globally. McConnell has consistently opposed the withdrawal since 2021, describing it as &#8220;one of the worst foreign policy decisions in American history.&#8221;
&#8220;We kept the lid on terrorism there. We shouldn't have withdrawn the troops,&#8221; said McConnell in the Fox interview. &#8220;When we did, that was like sending a green light to Putin, who was already thinking seriously about moving his troops up against the border."
Post-withdrawal, Russia invaded Ukraine. Ukrainian President Volodymyr Zelensky has frequently requested more aid from a divided Congress. The recently approved package will provide $61 billion to Ukraine for its war.
See Also: <a href="https://www.benzinga.com/news/24/04/38401616/biden-vs-trump-one-candidate-outperforms-his-2020-numbers-as-the-other-loses-support-among-2-key-vot?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Biden Vs. Trump: One Candidate Outperforms His 2020 Numbers As The Other Loses Support Among 2 Key Voter Categories</a>
Why It Matters: The U.S. withdrawal from Afghanistan has been a contentious issue. Gen. Frank McKenzie, former commander of the U.S. Central Command, warned of an <a href="https://www.benzinga.com/news/24/04/38016471/former-top-general-sounds-alarm-on-rising-isis-threat-to-us-bemoans-bidens-afghanistan-withdrawal">escalating ISIS threat</a> to the U.S. following the withdrawal.
President Biden, at the time, defended his decision, arguing that remaining in an endless war was <a href="https://www.benzinga.com/government/21/08/22524333/biden-defends-afghanistan-withdrawal-blames-kabuls-fall-on-afghan-military-leaders-and-trump">not in the best interests</a> of the American people.
However, Secretary of State Antony Blinken admitted in 2023 that the U.S. was not <a href="https://www.benzinga.com/news/23/04/31709570/blinken-says-us-wasnt-fully-prepared-for-afghanistan-crisis-as-white-house-puts-blame-on-donald-trum">fully prepared</a> for the fall of Kabul.
Recently, Russia warned of a &#8216;humiliating fiasco&#8217; for the U.S. in its support for Ukraine, <a href="https://www.benzinga.com/24/04/38349780/russia-foresees-humiliating-fiasco-for-us-in-ukraine-support-kremlin-drops-vietnam-and-afghanistan-r">drawing parallels</a> with Vietnam and Afghanistan.
Photo by Consolidated News Photos on Shutterstock
Read Next: <a href="https://www.benzinga.com/news/24/04/38356833/liz-cheney-says-trump-doing-everything-possible-to-postpone-jan-6-case-beyond-election-deep-flaws-in?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Liz Cheney Says Trump &#8216;Doing Everything Possible&#8217; To Postpone Jan. 6 Case Beyond Election: &#8216;Deep Flaws In Character…Make Him Unfit To Serve As President&#8217;</a>
<div style="font-family: 'Lato', sans-serif">
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by 
 Benzinga Neuro, Edited by 
 
 <a href="None" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none"> 
 Shivdeep Dhaliwal</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the 
 extensive Benzinga Ecosystem, including native data, APIs, and more to 
 create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>

General

Biden's Afghanistan Exit Slammed By Mitch McConnell: 'Like Sending A Green Light' To Russian President

The U.S. Supreme Court is preparing to review a case on Thursday that questions if former President Donald Trump can assert immunity from prosecution for actions carried out during his term in office.
What Happened: This case is the first of its kind where the Supreme Court is examining an appeal from one of Trump&#8217;s four criminal indictments. Trump&#8217;s defense, which claims immunity from prosecution even post-presidency, has been rejected by two lower courts previously, <a href="https://thehill.com/regulation/court-battles/4618415-supreme-court-to-consider-whether-president-trump-is-immune-from-prosecution/">reported</a> The Hill.
Three justices on the bench, Neil Gorsuch, Brett Kavanaugh, and Amy Coney Barrett, were nominated by Trump. However, the court&#8217;s verdict could potentially challenge Trump&#8217;s assertion that he should not be prosecuted.
Critics argue that a ruling favoring Trump could disrupt the balance of power in the U.S., giving undue authority to presidents during and after their term. Conversely, Trump maintains that the presidency cannot operate without immunity, as it would expose officeholders to extortion and unfair retribution.
&#8220;It's so fundamental to the presidency, where a president is truly trying to corrupt the system and perpetuate himself in office,&#8221; said John Dean, former White House counsel to President Richard Nixon, according to the report.
Jack Smith, the special counsel leading the federal prosecutors, argues that presidents, like all citizens, should be accountable for their actions. He dismisses the idea that this would weaken presidential power.
See Also: <a href="https://www.benzinga.com/news/24/04/38368085/what-happens-if-trump-gets-convicted-will-he-go-to-prison-heres-how-it-likely-to-play-out?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">What Happens If Trump Gets Convicted? Will He Go To Prison? — Here&#8217;s How It&#8217;s Likely To Play Out</a>
The Supreme Court&#8217;s decision timing could greatly affect the progress of Trump&#8217;s other criminal cases, particularly if he regains the presidency in the forthcoming election. The case is also being monitored for its potential impact on the scheduling of Trump&#8217;s trials.
Legal experts have observed that the lower courts&#8217; strong disapproval of Trump&#8217;s arguments might suggest a similar reaction from the conservative-majority Supreme Court. The justices&#8217; position will become more apparent when they convene on Thursday.
Why It Matters: Trump&#8217;s Supreme Court case, focusing on presidential immunity amid criminal charges for election interference, had strategic implications. While the Court might not fully support Trump&#8217;s immunity claim, a <a href="https://www.benzinga.com/news/24/04/38348880/donald-trump-could-still-win-even-if-he-loses-in-supreme-court-over-presidential-immunity-claim">redirection to a lower court</a>, potentially delaying proceedings, aligned with his interests. The case, involving false election certificates submitted by Trump, could have seen further delays and nuanced rulings regarding presidential immunity.
Adding to the complexity, Trump&#8217;s <a href="https://www.benzinga.com/news/24/04/38262159/trumps-request-to-attend-supreme-court-hearing-barrons-high-school-graduation-denied-by-hush-money-t">request to attend</a> the Supreme Court arguments was denied amidst his ongoing hush money trial in New York, as reported by <a href="https://www.benzinga.com/news/24/04/38262159/trumps-request-to-attend-supreme-court-hearing-barrons-high-school-graduation-denied-by-hush-money-t">Benzinga</a> earlier this month.
Photo courtesy: Shutterstock
Read Next: <a href="https://www.benzinga.com/news/24/04/38356833/liz-cheney-says-trump-doing-everything-possible-to-postpone-jan-6-case-beyond-election-deep-flaws-in?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Liz Cheney Says Trump &#8216;Doing Everything Possible&#8217; To Postpone Jan. 6 Case Beyond Election: &#8216;Deep Flaws In Character…Make Him Unfit To Serve As President&#8217;</a>
<div style="font-family: 'Lato', sans-serif">
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by 
 Benzinga Neuro, Edited by 
 
 <a href="None" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none"> 
 Shivdeep Dhaliwal</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the 
 extensive Benzinga Ecosystem, including native data, APIs, and more to 
 create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>

Trump's Presidential Immunity Claim Under Supreme Court Review: 'It's So Fundamental To The Presidency'

Former President Donald Trump&#8217;s close allies, including Boris Epshteyn, Mark Meadows, and Rudy Giuliani, have been indicted by an Arizona grand jury. The indictment pertains to their alleged involvement in attempts to overturn the 2020 election results.
What Happened: The Arizona grand jury handed down an indictment against several individuals associated with Trump&#8217;s 2020 campaign. These individuals stand accused of trying to subvert the election results, including the fraudulent electors from Arizona, <a href="https://edition.cnn.com/2024/04/24/politics/arizona-criminal-charges-2020-election-subversion/index.html">reported</a> CNN on Wednesday.
Among the indicted are Epshteyn, a former White House aide and one of Trump&#8217;s closest advisers, former White House chief of staff Meadows, and former New York Mayor Giuliani, as per a source familiar with the investigation, according to CNN .
See Also: <a href="https://www.benzinga.com/general/politics/24/04/38362005/donald-trump-may-soon-receive-36-million-more-djt-shares-key-milestone-ahead?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Donald Trump May Soon Receive An Additional $1.26B In DJT Shares: Key Milestone Ahead (UPDATED)</a>
Arizona Attorney General Kris Mayes announced the indictment on Wednesday night, focusing on the 11 individuals who acted as pro-Trump electors in the state. The names of several other indicted defendants remain redacted until they have been served, Mayes stated.
While Trump himself has not been charged in Arizona, the indictment details suggest he is referred to as &#8220;Unindicted Coconspirator 1&#8221;.
Why It Matters: The indictment of Trump&#8217;s allies in Arizona marks a significant development in the ongoing legal battles surrounding the 2020 election. 
In an interview with Fox News in August 2023, Rep. Marjorie Taylor Greene (R-Ga), a staunch Trump supporter, suggested that the ex-president could potentially <a href="https://www.benzinga.com/news/23/08/33956035/marjorie-taylor-greene-says-donald-trump-may-face-fifth-indictment-in-arizona?itm_source=parsely-api">face a fifth indictment</a>, this time in Arizona, based on a similar alleged fraudulent elector scheme aimed at undermining President Joe Biden&#8217;s narrow victory in the state. 
Image made using photos on Shutterstock
Read Next: <a href="https://www.benzinga.com/news/24/04/38349699/marjorie-taylor-greene-says-mike-johnsons-speakership-is-over-after-house-passes-ukraine-aid-package?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Marjorie Taylor Greene Says Mike Johnson&#8217;s Speakership Is &#8216;Over&#8217; After House Passes Ukraine Aid Package: &#8216;Resign And Allow Us To Move Forward&#8217;</a>
<div style="font-family: 'Lato', sans-serif">
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by 
 Benzinga Neuro, Edited by 
 
 <a href="None" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none"> 
 Shivdeep Dhaliwal</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the 
 extensive Benzinga Ecosystem, including native data, APIs, and more to 
 create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>

Trump Allies Giuliani, Meadows Indicted By Arizona Grand Jury For Alleged 2020 Election Subversion — Ex-President Possibly 'Unindicted Co-conspirator 1': Report

APDN

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

WNBA star Brittney Griner is sharing her story for the first time about spending 10 months in a Russian prison in a special edition of 20/20.
In a clip of the emotional interview, Griner shared her experience of having been <a href="https://www.benzinga.com/markets/cannabis/22/03/26007231/breaking-russia-detains-wnba-all-star-brittney-griner-for-alleged-possession-of-hash-oil">arrested and incarcerated</a> after a small amount of cannabis oil was found in her suitcase at a Moscow airport. At the time, Feb. 17, 2022 — just one week before Russia invaded Ukraine — Griner was heading back to Russia where she played for seven years during the off-season from her U.S. team, a center for the Phoenix Mercury.
"I was just so scared for everything because there&#8217;s so much unknown," Griner <a href="https://abcnews.go.com/US/wnba-star-brittney-griner-opens-harrowing-russian-detention/story?id=109495984">told</a> ABC's&nbsp;Robin Roberts,&nbsp;co-anchor of&nbsp;Good Morning America.
Roberts asked Griner what was going on in her mind when she realized that the cannabis cartridges were found in her luggage. Griner, a medical marijuana patient in the U.S., said she realized immediately that her mistake could have devastating consequences.
"My life is over right here," Griner answered. 
Griner admitted that the conditions were so terrible that she had thoughts of ending her life. "The mattress had a huge blood stain on it. I had no soap, no toilet paper. That was the moment where I just felt less than a human," she told Roberts. "I just didn&#8217;t think I could get through what I needed to get through.&#8221;
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="1st look at Brittney Griner&#039;s interview" width="500" height="281" src="https://www.youtube.com/embed/ovmtrgsjwYA?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
When Griner <a href="https://www.benzinga.com/markets/cannabis/22/07/27987966/breaking-brittney-griner-pleads-guilty-biden-lashes-out-over-her-detention-russia-calls-it-hype-">pleaded guilty to drug charges</a> in July 2022, she told a judge in Moscow that she accidentally packed the vape cartridges in her luggage and did not intentionally break Russian law. 
Sentenced to <a href="https://www.benzinga.com/markets/cannabis/22/08/28355539/closing-remarks-in-brittney-griner-case-verdict-and-sentencing-expected-soon">nine years in prison</a> in August, Griner was released on Dec. 8 in a prisoner swap for Russian arms dealer&nbsp;Viktor Bout. But not before being moved to a <a href="https://www.benzinga.com/markets/cannabis/22/11/29642858/brittney-griner-being-moved-to-russian-penal-colony-her-lawyers-dont-yet-know-exact-location">notorious penal colony</a>.
In addition to the exclusive interview, Griner&#8217;s <a href="https://www.benzinga.com/markets/cannabis/23/12/36147628/brittney-griner-will-exclusively-share-her-story-across-multiple-platforms-via-espn-disney-partn">story is the subject of an ESPN documentary</a> and a potential scripted series with ABC detailing her experience.
Photo: Courtesy of ESPN press room

Cannabis

Sports

Global

Media

Brittney Griner Talks For The First Time About Her Russian Detention In Exclusive '20/20' Special

For the first time in more than 130 years, voters will likely choose between two candidates with presidential experience for the <a href="https://www.benzinga.com/topic/2024-election">2024 presidential election.</a>
Here's a look at who voters in swing states currently favor in a 2020 election rematch of Donald Trump and Joe Biden.
What Happened: A close race is expected between Biden and Trump in the 2024 election based on election polls <a href="https://www.benzinga.com/general/sports-betting/24/04/38417836/trump-and-biden-get-ready-2024-election-betting-odds-point-to-major-showdown">and betting odds.</a>
Key demographics like young voters and old voters could play an important role in the election, along with <a href="https://www.benzinga.com/topic/swing-states">key swing states.</a>
A new poll of voters in swing states shows Biden gaining ground over Trump, who has led the way in these key states in recent months.
Here are the results of the recent swing state <a href="https://pro.morningconsult.com/analysis/swing-state-polling-april-2024">poll </a>from Morning Consult for the month of April, with the results from March in parentheses.
Arizona: 49% Trump (48%), 42% Biden (43%)
Georgia: 49% Trump (49%), 43% Biden (42%)
Michigan: 47% Biden (45%), 45% Trump (45%)
Nevada: 51% Trump (46%), 43% Biden (44%)
North Carolina: 51% Trump (49%), 41% Biden (43%)
Pennsylvania: 47% Trump (45%), 46% Biden (45%)
Wisconsin: 48% Trump (45%), 44% Biden (46%)
Related Link: <a href="https://www.benzinga.com/general/politics/24/04/38358680/can-biden-or-trump-build-ikea-furniture-2024-election-polls-may-have-gone-too-far">Can Biden Or Trump Build IKEA Furniture? 2024 Election Polls May Have Gone Too Far</a>
Why It's Important: The new poll shows Trump gaining support in Arizona, Nevada, North Carolina, Pennsylvania and Wisconsin. Trump has some of his biggest leads in Arizona, Nevada and North Carolina since polling began in October 2023 for the swing states.
Biden gained support in Georgia, Michigan and Pennsylvania, but lost support in several states. The key win for the current president is taking a lead in Michigan for the first time since polling began in October.
The new poll also showed Biden gaining voter trust on several items including Medicare and Social Security.
The <a href="https://www.benzinga.com/general/politics/24/03/37884006/trump-vs-biden-key-swing-states-arizona-nevada-michigan-wisconsin-show-close-races-heres-the-rol">seven swing states </a>together represent 93 electoral votes in the 2024 election. Six of the seven swing states were won by Biden in the 2020 election, with Trump winning North Carolina. Five of the seven swing states won by Biden in 2020 flipped from Trump to Biden in the election, including Arizona, Michigan and Wisconsin.
Read Next: <a href="https://www.benzinga.com/general/politics/24/04/38366379/trump-committed-conspiracy-to-undermine-the-integrity-of-a-presidential-election-prosecution-all">Trump Committed &#8216;Conspiracy To Undermine The Integrity Of A Presidential Election,&#8217; Prosecution Alleges In Hush Money Trial</a>
Photo: Shutterstock

Trump Vs. Biden: Former President Dominates Swing States, But Loses One For First Time In New 2024 Election Poll

If you're the parent of a child under 12 and have streaming platform Disney+, there's a good chance you've watched Australian <a href="https://www.benzinga.com/general/entertainment/23/12/36400565/is-disneys-percy-jackson-reboot-a-streaming-sensation-the-impact-of-new-shows-and-blueys-tr">animated hit &#8220;Bluey.</a>&#8220;
The show is turning in big numbers for Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>), but the company also hinted at the show ending or having less content going forward.
What Happened: Streaming platform Disney+, part of the Walt Disney Company, has one of the<a href="https://www.benzinga.com/general/entertainment/24/04/38024244/appletv-a-streaming-winner-new-survey-shows-platform-has-smallest-library-highest-rated-con"> largest content libraries</a> of family-based content, which is a draw to getting adults with children to subscribe to the platform.
Among the hit shows on Disney+ is the Australian show "Bluey," with Disney having the rights in the U.S. The show has drawn praise from kids and from parents, thanks to its relatable storylines.
On April 14, Disney+ aired the episode "The Sign" from the third season of the show. At 28 minutes, the episode was around three times longer than most episodes.
The episode had 10.4 million views globally in its first week on Disney+, <a href="https://www.hollywoodreporter.com/tv/tv-news/bluey-the-sign-ratings-disney-plus-1235879242/">according </a>to The Hollywood Reporter. This ranked as the most-watched episode in the show's history and had the biggest viewership for a Disney Junior show on Disney+.
This episode and its predecessor "Ghostbasket" left fans asking questions about the future as the Heeler family featured on "Bluey" dealt with a potential sale of their home and a move to another city.
Fans were treated to a surprise with the season 3 finale episode appropriately titled, "Surprise."
The episode included a flash forward to main character Bluey as an adult and with a child —&nbsp;leaving more questions about if the show is ending, as many voiced on social media that it felt more like a series finale than a season finale.
Related Link:<a href="https://www.benzinga.com/news/earnings/24/02/36993564/disney-invests-1-5b-in-fortnite-owner-epic-games-in-biggest-ever-gaming-entry-posts-q1-earnings-bea"> Disney Invests $1.5B In Fortnite Owner Epic Games In &#8216;Biggest Ever&#8217; Gaming Entry, Posts Q1 Earnings Beat, Revenue Miss</a>
What's Next: Show creator Joe Brumm told The Hollywood Reporter in 2023 that the BBC, which originally commissioned the show alongside Australia's ABC, to not talk about the kids' voices or the future of the show.&nbsp;
Brumm has also said he's taking a break after the third season, which added to the speculation about the show's future.&nbsp;
A producer of "Bluey" recently confirmed to <a href="https://www.bbc.com/news/entertainment-arts-68795941">BBC </a>that the show will return in the future. Another producer also said it would be a "dream" to make a movie based on Bluey and her family in the future.
"Bluey" debuted on the streaming platform in 2020, becoming one of the most-watched shows in the U.S. on streaming platforms. Data from Nielsen showed the series had an average of 1.19 billion minutes viewed per week across a three-season library of 150 episodes.
The children's show is the most streamed show in the U.S. in 2024 based on viewing time tracked by Nielsen. The show ranked second in 2023 and sixth in 2022.
The show has been a huge hit for Disney and a gap between seasons or an end to the show could eliminate one of the key pieces of content.&nbsp;
In a highly competitive streaming market, platforms need shows like "Bluey" that aren't available other places and are must-watch content for at least one age demographic.
With its appeal to kids and parents alike, "Bluey" hits multiple demographics.
Read Next: <a href="https://www.benzinga.com/general/entertainment/24/03/37701205/taylor-swift-concert-film-hits-streaming-heres-how-to-watch-the-eras-tour-taylors-version">Taylor Swift Concert Film Hits Streaming: Here&#8217;s How To Watch &#8216;The Eras Tour (Taylor&#8217;s Version)&#8217;</a>
Photo: Courtesy Disney+ UK

Bluey Dominates Ratings For Disney+: Kids, Parents Hoping Hit Show Not Over

<h1 class="wp-block-heading">Top Stories for April 24, 2024:</h1>
<ol>
<li>American Battery Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABAT#NASDAQ">ABAT</a>) updated <a href="https://www.benzinga.com/news/24/04/38404516/american-battery-technology-company-publishes-updated-initial-assessment-and-economic-analysis-for-t">its initial assessment</a> for the Tonopah Flats Lithium Project (TFLP).</li>
</ol>
It refined the project&#8217;s scope to use only measured and indicated mineral resources, excluding the more speculative inferred resources.&nbsp;
This strategy improves the project's economics by enhancing access to higher-quality resources and optimizing processing at its newly built demonstration facility. 
Key updates include a 7% reduction in total processed claystone, an 8% increase in lithium grade, a 7% decrease in production costs and a 6% rise in the project&#8217;s net present value to $4.67 billion.
<ol start="2">
<li>Steel Dynamics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>) reported first-quarter results, with net sales of $4.7 billion and net income of $584 million. </li>
</ol>
Highlights include 3.3 million tons of steel shipments, operating income of $751 million and adjusted EBITDA of $879 million.&nbsp;
The company&#8217;s financial health was further supported by liquidity of $3.1 billion and shareholder returns through $298 million in stock repurchases and an 8% dividend increase.&nbsp;
Demand was solid across sectors, particularly automotive and construction, driving sequential improvements in earnings and operational performance.
Also Read:<a href="https://www.benzinga.com/topic/mining"> </a><a href="https://www.benzinga.com/news/24/04/38390383/copper-prices-approach-2-year-highs-whats-behind-analysts-12-000-price-prediction-for-2026">Copper Prices Approach 2-Year Highs: What&#8217;s Behind Analyst&#8217;s $12,000 Price Prediction For 2026?</a>
<ol start="3">
<li>Gold Royalty Corp (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GROY#AMEX">GROY</a>) entered into a three-year mutual cooperation agreement with Taurus Mining Royalty Fund that allows both parties to co-invest in precious metals royalties and streams. </li>
</ol>
The agreement focuses on assets valued at $30 million or more and provides a framework for identifying and evaluating co-investment opportunities, with the option for each party to invest 25% to 50% in selected transactions.&nbsp;
Additionally, any future sales of interests acquired through this partnership will offer first rights to the other partner.
<ol start="4">
<li>Coeur Mining Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDE#NYSE">CDE</a>) released its 2023 ESG Report, emphasizing its progress in environmental, social and governance efforts aligned with shareholder value. </li>
</ol>
The report highlights Coeur&#8217;s achievement of the lowest injury rate among peers at 0.46 and its adoption of the Global Industry Standard on Tailings Management (placing it among the top 17% of non-International Council on Mining and Metals companies).
The company also shared its commitment to biodiversity through the Biodiversity Management Standard and advancements in climate resilience, aiming for a 35% reduction in GHG emissions by the end of 2024.
Now Read:<a href="https://www.benzinga.com/"> </a><a href="https://www.benzinga.com/m-a/24/04/38405991/equinox-gold-snaps-up-greenstone-gold-mines-for-995m-in-incredibly-rare-deal">Equinox Gold Snaps Up Greenstone Gold Mines For $995 Million In &#8216;Incredibly Rare&#8217; Deal</a>
Benzinga Mining is the bridge between mining companies and retail investors. Reach out to <a href="mailto:licensing@benzinga.com">licensing@benzinga.com</a> to get connected with the Benzinga community!
Photo: Jose Luis Stephens via Shutterstock.

Commodities

ABAT

GROY

STLD

American Battery Optimizes Lithium Project; Steel Dynamics Reports Q1 Results; Gold Royalty Teams Up With Taurus Mining And More: Wednesday's Top Mining Stories

Helix Energy Solns Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLX#NYSE">HLX</a>) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $0.02 by 250 percent. The company reported quarterly sales of $296.211 million which missed the analyst consensus estimate of $296.725 million by 0.17 percent. This is a 18.44 percent increase over sales of $250.084 million the same period last year.

Earnings

Earnings Misses

Helix Energy Solns Gr Q1 2024 Adj EPS $(0.03) Misses $0.02 Estimate, Sales $296.211M Miss $296.725M Estimate

National Bank Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBHC#NYSE">NBHC</a>) reported quarterly earnings of $0.82 per share which beat the analyst consensus estimate of $0.76 by 7.89 percent. This is a 22.64 percent decrease over earnings of $1.06 per share from the same period last year. The company reported quarterly sales of $101.724 million which missed the analyst consensus estimate of $103.683 million by 1.89 percent. This is a 7.15 percent decrease over sales of $109.554 million the same period last year.

Earnings Beats

NBHC

National Bank Holdings Q1 2024 GAAP EPS $0.82 Beats $0.76 Estimate, Sales $101.724M Miss $103.683M Estimate

In June 2022, New York Gov. Kathy Hochul announced a deal had finally been reached to <a href="https://www.benzinga.com/markets/cannabis/22/01/24932856/new-york-gov-kathy-hochul-pledges-200m-to-boost-social-equity-efforts-as-part-of-cannabis-legali">fund a $200 million public-private effort</a>, which would finance cannabis dispensaries run by the people who have been the most impacted by the war on drugs.
The much-anticipated public-private fund is now coming under scrutiny following an <a href="https://www.thecity.nyc/2024/04/24/cannabis-fund-social-equity-dispensary/">investigation</a> by THE CITY&#8217;s Rosalind Adams, which uncovered a "lopsided deal" favoring the private equity firm Chicago Atlantic Group and raising concerns about the state's social equity goals. 
The agreement heavily favors Chicago Atlantic, leaving the state exposed to significant risks, noted the outlet.
Even the New York Office of Cannabis Management (OCM) cast doubts on the fund&#8217;s viability according to internal OCM documents that questioned whether the deal had overstated the potential revenue and profit potential.
<h1 class="wp-block-heading">What Happened</h1>
New York state, unable to secure a private equity partner, agreed to a $50 million loan from Chicago Atlantic at a 15% interest rate, with all risk borne by the state.
Critics, including Reinvent Albany, an organization that advocates for government transparency and accountability, deemed the deal to have been detrimental to the state and prospective dispensary owners. Legal experts and consultants likened it to distressed debt lending.
Despite the skepticism and advice against the arrangement, negotiations ultimately led to a secret agreement benefiting Chicago Atlantic.
Previously, THE CITY revealed how cannabis licensees who accept loans from the social equity fund are burdened with high construction costs that they don't control and with interest rates that exceed the state's initial estimates.
"Everyone is worried about defaulting because of the rules and regulations of this loan," said Roland Conner, who runs <a href="https://www.benzinga.com/markets/cannabis/23/01/30496199/ny-gov-hochul-announces-opening-of-first-cannabis-shop-owned-by-person-impacted-by-war-on-drugs">Smacked on Bleecker Street</a> in Greenwich Village, the first legal dispensary owned by a person affected by the drug war.
<h1 class="wp-block-heading">Who's Responsible?</h1>
Details of the deal are still secret, with New York state authorities denying Freedom of Information Law requests. The state comptroller&#8217;s office and key lawmakers say they were not informed or involved in the making of the deal, exposing a shocking lack of oversight.
Meanwhile, Chicago Atlantic secured favorable terms, including leasing rights and a $100 million commitment for property development, raising yet more concerns about profiteering at the expense of marginalized communities.
<h1 class="wp-block-heading">Corruption Or Ineptitude?</h1>
The handling of New York&#8217;s cannabis program seems to reflect a corrosive mix of both ineptitude and potential corruption. While officials may have sought to support marginalized groups, their actions suggest a lack of due diligence and transparency.
One element of the story, which you can read in full <a href="https://www.thecity.nyc/2024/04/24/cannabis-fund-social-equity-dispensary/">here</a>, is that social equity applicants are furious.
A Queens shop owner, Dalessio, who was awarded a retail license designated for people impacted by past drug convictions told THE CITY that after a year of back and forth with the fund, he walked away from the deal.
"It just left such a bad taste in my mouth. I warned everyone I could to stay away from this deal," he said.
Photo: Courtesy of Branding Pot via Shutterstock

Government

Legal

Cannabis Saga In The Empire State: Corruption Or Ineptitude? Private Equity Tramples Social Equity, Report Reveals

Alamos Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGI#NYSE">AGI</a>) reported quarterly Adj earnings of $0.13 per share which met the analyst consensus estimate. The company reported quarterly sales of $277.600 million which beat the analyst consensus estimate of $272.000 million by 2.06 percent. This is a 10.38 percent increase over sales of $251.500 million the same period last year.

Alamos Gold Q1 Adj EPS $0.13, Inline, Sales $277.600M Beat $272.000M Estimate

Piper Sandler analyst Clarke Jeffries maintains Tyler Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TYL#NYSE">TYL</a>) with a Overweight and maintains $520 price target.

Price Target

Analyst Ratings

Piper Sandler Maintains Overweight on Tyler Technologies, Maintains $520 Price Target

Rogers, who will continue to serve as a director of Mativ and will assume the role of Audit Committee Chair.

Management

MATV

Mativ Holdings Appoints Kimberly Ritrievi As Chair Of Board, Succeeding John Rogers

First Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBMS#NASDAQ">FBMS</a>) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.59 by 10.17 percent. This is a 24.42 percent decrease over earnings of $0.86 per share from the same period last year. The company reported quarterly sales of $57.341 million which missed the analyst consensus estimate of $59.927 million by 4.32 percent. This is a 11.68 percent decrease over sales of $64.926 million the same period last year.

FBMS

First Bancshares Q1 2024 Adj EPS $0.65 Beats $0.59 Estimate, Sales $57.341M Miss $59.927M Estimate

Guidance

Veris Residential Raises FY24 Core FFO Per Share Outlook From $0.48-$0.53 To $0.50-$0.54, Est $0.53

Colony Bankcorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBAN#NASDAQ">CBAN</a>) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.31 by 6.45 percent. This is a 6.45 percent increase over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $28.141 million which beat the analyst consensus estimate of $27.600 million by 1.96 percent. This is a 0.30 percent decrease over sales of $28.227 million the same period last year.

CBAN

Colony Bankcorp Q1 2024 Adj EPS $0.33 Beats $0.31 Estimate, Sales $28.141M Beat $27.600M Estimate

Needham analyst Mike Matson maintains Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) with a Buy and raises the price target from $71 to $82.

Needham Maintains Buy on Boston Scientific, Raises Price Target to $82

Shuttle Pharmaceuticals reports Q2 results

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are among the biggest topics worth checking on Tuesday and we have the latest news!
Moving stocks today are clinical trial data,&nbsp; public stock offerings and more.
Let&rsquo;s get into that below!

<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>
<ol>
<li>Femasys (NASDAQ:<a href="https://investorplace.com/stock-quotes/femy-stock-quote/">FEMY</a>) stock is rocketing more than 191% after getting <a href="https://www.nasdaq.com/press-release/femasys-inc.-receives-u.s.-fda-clearance-to-market-femaseed-an-innovative-infertility">approval for its infertility treatment</a>.</li>
<li>Tharimmune (NASDAQ:<a href="https://investorplace.com/stock-quotes/thar-stock-quote/">THAR</a>) shares are soaring over 88% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317765628&amp;type=PDF&amp;symbol=THAR&amp;cdn=c2763738d4d25a765b14cfb6f6a90fd6&amp;companyName=Tharimmune+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2023-09-25">after changing its name</a>.</li>
<li>Safe &amp; Green Development&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/sgdvv-stock-quote/">SGDVV</a>) stock is surging more than 72% ahead of its <a href="https://finance.yahoo.com/news/safe-green-holdings-corp-announces-120000886.html">distribution of shares in a spinoff tomorrow</a>.</li>
<li>Immunovant (NASDAQ:<a href="https://investorplace.com/stock-quotes/imvt-stock-quote/">IMVT</a>) shares are rising over 41% with <a href="https://seekingalpha.com/news/4015276-immunovant-climbs-on-phase-1-data-for-autoimmune-drug?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain">positive Phase 1 clinical trial data</a>.</li>
<li>Moleculin Biotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/mbrx-stock-quote/">MBRX</a>) stock is increasing more than 34% on Tuesday morning.</li>
<li>Infobird (NASDAQ:<a href="https://investorplace.com/stock-quotes/ifbd-stock-quote/">IFBD</a>) shares are gaining over 33% with heavy pre-market trading this morning.</li>
<li>Shuttle Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/shph-stock-quote/">SHPH</a>) stock is climbing more than 24% alongside results of a <a href="https://www.nasdaq.com/press-release/shuttle-pharma-announces-results-of-pre-ind-meeting-with-fda-for-ropidoxuridine-phase">Food and Drug Administration (FDA) meeting</a>.</li>
<li>Pliant Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/plrx-stock-quote/">PLRX</a>) shares are getting an over 20% boost alongside <a href="https://www.streetinsider.com/Special+Reports/After-hours+movers%3A+Pliant+Therapeutics+gains+ahead+of+data%2C+Coty+falls+on+offering/22196487.html">Phase 2a clinical trial data</a>.</li>
<li>Avalo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/avtx-stock-quote/">AVTX</a>) stock is jumping more than 18% after <a href="https://www.nasdaq.com/press-release/avalo-therapeutics-successfully-eliminates-%2435-million-debt-paving-the-way-for-future">cutting its debt</a>.</li>
<li>Akumin (NASDAQ:<a href="https://investorplace.com/stock-quotes/aku-stock-quote/">AKU</a>) shares are up over 18% on Tuesday.</li>
</ol>
<h2>10 Top Losers</h2>
<ol>
<li>TransCode Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/rnaz-stock-quote/">RNAZ</a>) stock is crashing more than 70% after <a href="https://finance.yahoo.com/news/transcode-therapeutics-announces-pricing-8-000100176.html">pricing a public offering</a>.</li>
<li>Safe &amp; Green (NASDAQ:<a href="https://investorplace.com/stock-quotes/sgbxv-stock-quote/">SGBXV</a>) shares are plummeting over 22% ahead of its spinoff tomorrow.</li>
<li>Safe &amp; Green (NASDAQ:<a href="https://investorplace.com/stock-quotes/sgbx-stock-quote/">SGBX</a>) stock is also diving more than 20% for the same reason.</li>
<li>Conduit Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/cdt-stock-quote/">CDT</a>) shares are tumbling over 18% following its <a href="https://www.marketwatch.com/story/conduit-pharma-shares-fall-40-on-nasdaq-debut-79be9688">public debut yesterday</a>.</li>
<li>ESGL Holdings (NASDAQ:<a href="https://investorplace.com/stock-quotes/esgl-stock-quote/">ESGL</a>) stock is taking a more than 17% beating without any clear news this morning.</li>
<li>Jet AI (NASDAQ:<a href="https://investorplace.com/stock-quotes/jtai-stock-quote/">JTAI</a>) shares are falling over 17% after a rally on Monday.</li>
<li>Polished.com (NYSEMKT:<a href="https://investorplace.com/stock-quotes/pol-stock-quote/">POL</a>) stock is dropping more than 16% today.</li>
<li>Digital Brands (NASDAQ:<a href="https://investorplace.com/stock-quotes/dbgi-stock-quote/">DBGI</a>) shares are slipping over 15% after announcing a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317766381&amp;type=PDF&amp;symbol=DBGI&amp;cdn=054fed580cffceab06023428b9199ccb&amp;companyName=Digital+Brands+Group+Inc.&amp;formType=424B3&amp;formDescription=Prospectus+%5BRule+424%28b%29%283%29%5D&amp;dateFiled=2023-09-26">prospective stock offering</a>.</li>
<li>Biophytis (NASDAQ:<a href="https://investorplace.com/stock-quotes/bpts-stock-quote/">BPTS</a>) stock is dipping more than 15% after <a href="https://investorplace.com/2023/09/why-is-biophytis-bpts-stock-up-49-today/">a major rally yesterday</a>.</li>
<li>Omega Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/omga-stock-quote/">OMGA</a>) shares close out our pre-market stock movers down over 12% <a href="https://www.nasdaq.com/press-release/omega-therapeutics-announces-promising-preliminary-clinical-data-for-otx-2002-from">with its latest clinical trial news</a>.</li>
</ol>
On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
<ul>
<li>
						<a href="https://investorplace.com/2023/07/venture-capitalist-predicts-this-chatgpt-announcement-will-shock-the-world/?cid=MKT744191&amp;eid=MKT758392">ChatGPT IPO Could Shock the World, Make This Move Before the Announcement</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT758390">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT758396">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
</ul>
<div>
<div>
<div></div>
<div></div>
</div>
</div>
The post <a href="https://investorplace.com/2023/09/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-sept-26th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Shuttle Pharmaceuticals reports Q3 results

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has released an update to notify the public and investors about an entry into a material definitive a...

Shuttle Pharmaceuticals Acquires Promising Prostate Cancer Technology

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has released an update. The Company has partnered with John Columbia Inc. to boost its investor relat...

Shuttle Pharmaceuticals Bolsters Investor Relations with New Partnership

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has released an update. Shuttle Pharmaceuticals Holdings, Inc. has entered into an agreement with SRO...

Shuttle Pharmaceuticals Advances Prostate Cancer Diagnostics Funding

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Shuttle Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/shph-stock-quote/">SHPH</a>) just reported results for the fourth quarter of 2023.<ul><li>Shuttle Pharmaceuticals reported earnings per share of -11 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/03/shph-stock-earnings-shuttle-pharmaceuticals-for-q4-of-2023/">SHPH Stock Earnings: Shuttle Pharmaceuticals Reported Results for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SHPH Stock Earnings: Shuttle Pharmaceuticals Reported Results for Q4 2023

Shuttle Pharmaceuticals files to sell subscription rights to buy $4.5M in units

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
The trading week starts with a dive into the biggest pre-market stock movers worth keeping tabs on for Monday morning!



Moving stocks this morning are public offerings, delisting notices, dividends and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Hub Cyber Security (NASDAQ:<a href="https://investorplace.com/stock-quotes/hubc-stock-quote/">HUBC</a>) stock is rocketing more than 44% alongside heavy pre-market trading.</li>



<li>Longeveron (NASDAQ:<a href="https://investorplace.com/stock-quotes/lgvn-stock-quote/">LGVN</a>) shares are soaring over 44% after <a href="https://www.nasdaq.com/press-release/longeveron-announces-closing-of-%245.2-million-public-offering-2024-04-11">closing a public offering</a> <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318233823&amp;type=PDF&amp;symbol=LGVN&amp;cdn=a770dc64078369c76023bc924ed74b50&amp;companyName=Longeveron+Inc.&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-04-12">and insider buying</a>.</li>



<li>Allarity Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/allr-stock-quote/">ALLR</a>) stock is surging more than 37% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318232384&amp;type=PDF&amp;symbol=ALLR&amp;cdn=b9395315130771ba262873e0f9f45c59&amp;companyName=Allarity+Therapeutics+Inc.&amp;formType=424B5&amp;formDescription=Prospectus+%5BRule+424%28b%29%285%29%5D&amp;dateFiled=2024-04-12">amending its sales agreement</a>.</li>



<li>Snap One (NASDAQ:<a href="https://investorplace.com/stock-quotes/snpo-stock-quote/">SNPO</a>) shares are rising over 29% after announcing <a href="https://www.nasdaq.com/press-release/resideo-to-acquire-snap-one-to-expand-presence-in-smart-living-products-and">an acquisition deal</a>.</li>



<li>Piedmont Lithium (NASDAQ:<a href="https://investorplace.com/stock-quotes/pll-stock-quote/">PLL</a>) stock is gaining more than 23% after getting <a href="https://www.nasdaq.com/press-release/piedmont-lithium-receives-mining-permit-approval-for-carolina-lithium-2024-04-15">mining permit approval</a>.</li>



<li>SuperCom (NASDAQ:<a href="https://investorplace.com/stock-quotes/spcb-stock-quote/">SPCB</a>) shares are rising over 16% with incredibly strong early morning movement.</li>



<li>Leafly (NASDAQ:<a href="https://investorplace.com/stock-quotes/lfly-stock-quote/">LFLY</a>) stock is flying more than 16% higher after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318232734&amp;type=PDF&amp;symbol=LFLY&amp;cdn=fac5fc6f5ecd43707f276b2f37608568&amp;companyName=Leafly+Holdings+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-12">falling Friday on delisting news</a>.</li>



<li>Allakos (NASDAQ:<a href="https://investorplace.com/stock-quotes/allk-stock-quote/">ALLK</a>) shares are increasing over 15% without any clear news this morning.</li>



<li>Medical Properties Trust (NYSE:<a href="https://investorplace.com/stock-quotes/mpw-stock-quote/">MPW</a>) stock is jumping more than 14% after <a href="https://finance.yahoo.com/news/medical-properties-trust-declares-regular-202000224.html">declaring its quarterly dividend</a>.</li>



<li>Marine Petroleum Trust (NASDAQ:<a href="https://investorplace.com/stock-quotes/marps-stock-quote/">MARPS</a>) shares are up over 13% despite a lack of news today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>AudioEye (NASDAQ:<a href="https://investorplace.com/stock-quotes/aeye-stock-quote/">AEYE</a>) stock is plummeting more than 34% on Monday morning.</li>



<li>Neumora Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/nmra-stock-quote/">NMRA</a>) shares are diving over 23% after <a href="https://www.nasdaq.com/press-release/neumora-therapeutics-announces-clinical-hold-of-phase-1-nmra-266-study-2024-04-15">announcing a clinical hold</a> on a Phase 1 trial.</li>



<li>NextPlat (NASDAQ:<a href="https://investorplace.com/stock-quotes/nxpl-stock-quote/">NXPL</a>) stock is tumbling more than 19% <a href="https://investorplace.com/2024/04/why-is-nextplat-nxpl-stock-up-34-today/">following a Friday rally</a>.</li>



<li>Mobile Global Esports (NASDAQ:<a href="https://investorplace.com/stock-quotes/mgam-stock-quote/">MGAM</a>) shares are taking an over 18% beating <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318232971&amp;type=PDF&amp;symbol=MGAM&amp;cdn=16491c2c834a89973f90cd665be062a9&amp;companyName=Mobile+Global+Esports+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-12">on delisting news</a>.</li>



<li>IM Cannabis (NASDAQ:<a href="https://investorplace.com/stock-quotes/imcc-stock-quote/">IMCC</a>) stock is sliding more than 17% without any obvious news to report.</li>



<li>Beneficient (NASDAQ:<a href="https://investorplace.com/stock-quotes/benf-stock-quote/">BENF</a>) shares are dropping over 17% on Monday morning.</li>



<li>Tracon Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/tcon-stock-quote/">TCON</a>) stock is decreasing more than 13% after warning investors it only has enough cash to operate <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318233346&amp;type=PDF&amp;symbol=TCON&amp;cdn=d702801afb8d5bee35038dce1c2e4efc&amp;companyName=TRACON+Pharmaceuticals+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-12">until late Q3 2024</a>.</li>



<li>Cyngn (NASDAQ:<a href="https://investorplace.com/stock-quotes/cyn-stock-quote/">CYN</a>) shares are falling over 13% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318233680&amp;type=PDF&amp;symbol=CYN&amp;cdn=5af092c6fdb596a429dfa66036eafcc1&amp;companyName=Cyngn+Inc.&amp;formType=S-1&amp;formDescription=Registration+statement+under+Securities+Act+of+1933&amp;dateFiled=2024-04-12">proposed public offering</a>.</li>



<li>OncoCyte (NASDAQ:<a href="https://investorplace.com/stock-quotes/ocx-stock-quote/">OCX</a>) stock is slipping more than 12% alongside its <a href="https://finance.yahoo.com/news/oncocyte-reports-full-2023-financial-100000423.html">latest earnings report</a>.</li>



<li>Shuttle Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/shph-stock-quote/">SHPH</a>) shares close out our pre-market stock movers down 12% this morning.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-april-15th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth diving into on Tuesday as we check out all of the biggest changes and the news behind them!



Moving stocks this morning are earnings reports, an acquisition agreement, proposed public offerings and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Dynatronics (NASDAQ:<a href="https://investorplace.com/stock-quotes/dynt-stock-quote/">DYNT</a>) stock is rocketing more than 97% alongside heavy pre-market trading.</li>



<li>Dragonfly Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/dfli-stock-quote/">DFLI</a>) shares are soaring close to 55% after releasing its <a href="https://www.nasdaq.com/press-release/dragonfly-energy-reports-fourth-quarter-2023-and-full-year-financial-results-2024-04">Q4 2023 earnings report</a>.</li>



<li>Macatawa Bank (NASDAQ:<a href="https://investorplace.com/stock-quotes/mcbc-stock-quote/">MCBC</a>) stock is surging over 38% after <a href="https://www.globenewswire.com/news-release/2024/04/15/2863147/11955/en/Wintrust-Financial-Corporation-and-Macatawa-Bank-Corporation-Announce-Plans-to-Merge.html">signing an acquisition agreement</a>.</li>



<li>WiSA Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/wisa-stock-quote/">WISA</a>) shares are rising more than 26% <a href="https://www.nasdaq.com/press-release/wisa-technologies-announces-reverse-stock-split-2024-04-10">following a reverse stock split</a>.</li>



<li>Mobilicom (NASDAQ:<a href="https://investorplace.com/stock-quotes/mob-stock-quote/">MOB</a>) stock is gaining over 21% on plans to show off an <a href="https://www.nasdaq.com/press-release/mobilicom-to-unveil-unprecedented-comprehensive-solution-for-uncrewed-vehicle-systems">uncrewed vehicle system</a>.</li>



<li>HNR Acquisition (NYSEMKT:<a href="https://investorplace.com/stock-quotes/hnra-stock-quote/">HNRA</a>) shares are increasing more than 18% without any clear news this morning.</li>



<li>Shuttle Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/shph-stock-quote/">SHPH</a>) stock is climbing over 18% despite a lack of news.</li>



<li>Taoping (NASDAQ:<a href="https://investorplace.com/stock-quotes/taop-stock-quote/">TAOP</a>) shares are getting a more than 16% boost without any obvious news to report.</li>



<li>Global Gas (NASDAQ:<a href="https://investorplace.com/stock-quotes/hgas-stock-quote/">HGAS</a>) stock is jumping over 16% on Tuesday morning.</li>



<li>Kaixin (NASDAQ:<a href="https://investorplace.com/stock-quotes/kxin-stock-quote/">KXIN</a>) shares are up more than 14% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Ryvyl (NASDAQ:<a href="https://investorplace.com/stock-quotes/rvyl-stock-quote/">RVYL</a>) stock is diving over 29% on a <a href="https://www.nasdaq.com/press-release/ryvyl-inc.-announces-launch-of-proposed-underwritten-public-offering-2024-04-15">proposed public offering</a>.</li>



<li>Calidi Biotherapeutics (NYSEMKT:<a href="https://investorplace.com/stock-quotes/cldi-stock-quote/">CLDI</a>) shares are tumbling more than 22% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318234211&amp;type=PDF&amp;symbol=CLDI&amp;cdn=ab45db11645ce0b64dd38dde47e4a59d&amp;companyName=Calidi+Biotherapeutics+Inc.&amp;formType=S-1%2FA&amp;formDescription=%5BAmend%5D+General+form+for+registration+of+securities+under+the+Securities+Act+of+1933&amp;dateFiled=2024-04-15">proposed public offering</a>.</li>



<li>Inovio Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/ino-stock-quote/">INO</a>) stock is taking an over 22% beating after <a href="https://finance.yahoo.com/news/inovio-announces-pricing-approximately-36-223900148.html">pricing an underwritten offering</a>.</li>



<li>MDJM (NASDAQ:<a href="https://investorplace.com/stock-quotes/mdjh-stock-quote/">MDJH</a>) shares are sliding more than 15% on Tuesday morning.</li>



<li>Addex Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/adxn-stock-quote/">ADXN</a>) stock is dropping over 12% this morning.</li>



<li>Qilian (NASDAQ:<a href="https://investorplace.com/stock-quotes/qli-stock-quote/">QLI</a>) shares are decreasing more than 10% today.</li>



<li>Indonesia Energy (NYSEMKT:<a href="https://investorplace.com/stock-quotes/indo-stock-quote/">INDO</a>) stock is falling over 10% this morning.</li>



<li>US Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/useg-stock-quote/">USEG</a>) shares are slipping more than 10% on Tuesday.</li>



<li>Poseida Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/pstx-stock-quote/">PSTX</a>) stock is dipping over 9% today.</li>



<li>OMNIQ (NASDAQ:<a href="https://investorplace.com/stock-quotes/omqs-stock-quote/">OMQS</a>) shares close out our pre-market stock movers down more than 9%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-april-16th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

AEYE